Day: May 9, 2024

Posted on

King Faisal Specialist Hospital & Research Centre Leading Health Sector Transformation in Saudi Arabia

King Faisal Specialist Hospital & Research Centre Leading Health Sector Transformation in Saudi Arabia

RIYADH, Saudi Arabia, May 09, 2024 (GLOBE NEWSWIRE) — Harvard University — Eight years into Vision 2030, Saudi Arabia has made significant strides with digital innovations and enhanced access to quality care. Strategic investments in infrastructure, technology, and talent, have led to advancements revolutionizing patient care delivery and elevating the standards of healthcare locally. These efforts have notably raised the average life expectancy, reduced mortality rates, and enhanced overall well-being across the Kingdom.

Central to these achievements, King Faisal Specialist Hospital & Research Centre (KFSH&RC), renowned for its specialized care and treatments across critical fields such as oncology, cardiology, organ transplantation, and genetics has positioned itself as a leader in specialized patient care, taking the charge towards a brighter, healthier future for the Kingdom. Through its commitment to pioneering digital health initiatives, comprehensive educational programs, and novel research endeavors, it is reshaping the local landscape, and setting new standards of efficiency and accessibility.

In an era defined by technological advancements, and with the Kingdom’s push towards digitalization, KFSH&RC stands at the forefront of digital health integration among its local peers, leveraging cutting-edge telemedicine services, virtual consultations, and AI-driven tools such as the ANFAL AI System that transforms patient outcomes through predictive insights and personalized care, ensuring the best outcomes for patient satisfaction.

KFSH&RC’s digital health initiatives extend to addressing broader health threats through technologies such as Whole Genomic Sequencing (WGS) and Advanced Radiation Therapy. The hospital has also pioneered organ transplantation by performing the world’s first fully robotic liver transplant and introduced to the region innovations like the Harmony Transcatheter Pulmonary Valve (TPV), enhancing patient recovery and experience. These technologies facilitate personalized treatment plans and improve the accuracy and speed of medical diagnostics, contributing significantly to the elevation of patient care standards and a sustainable, resilient healthcare infrastructure in line with the objectives of the Health Sector Transformation Program.

KFSH&RC continues to push the boundaries of medical research addressing pressing health challenges and contributing to Saudi Arabia’s public health landscape, with discoveries like the PfAP2-MRP gene crucial for malaria treatment and the identification of the new Riyadhensis bacteria strain. These discoveries have not only improved diagnostic accuracy but also facilitated early interventions, ensuring timely and effective patient support, in line with the national objectives to reduce chronic disease prevalence.

These comprehensive efforts are supported by KFSH&RC’s robust educational initiatives, which prepare the next generation of medical professionals through training programs and international collaborations.

Recognized by ‘Brand Finance’ in 2024 as the most valuable healthcare brand in Saudi Arabia and the Middle East for the second consecutive year, placing 9th in Saudi Arabia and 28th in the Middle East. Additionally, KFSH&RC stands out as the only hospital worldwide to be ranked among its country’s top ten most valuable brands.

About King Faisal Specialist Hospital & Research Centre (KFSH&RC):

King Faisal Specialist Hospital & Research Centre (KFSH&RC) stands as a leading healthcare institution in the Middle East, envisioned to be the optimal choice for every patient seeking specialized healthcare. The hospital boasts a rich history in the treatment of cancers, cardiovascular diseases, organ transplantation, neurosciences, and genetics.

In 2024, “Brand Finance” ranked King Faisal Specialist Hospital & Research Centre as the top academic medical centre in the Middle East and Africa, and among the top 20 globally for the second consecutive year. Additionally, in 2024, it was recognized as one of the leading global healthcare providers by Newsweek magazine.

As part of Saudi Vision 2030, a royal decree was issued on December 21, 2021, to transform the hospital into an independent, non-profit, government-owned entity, paving the way for a comprehensive transformation program aimed at achieving global leadership in healthcare through excellence and innovation.

CONTACT INFORMATION

For more information, please contact:

Mr. Essam Al-Zahrani, Media Affairs Head, 0555254429

Mr. Abdullah Al-Aown, Media Coordination Officer, 0556294232

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/003e76ab-3d93-42d4-9edf-5e652a14c559

Copyright © 2024 GlobeNewswire, Inc.

GlobeNewswire Distribution ID 9114722

Posted on

Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest

Curia & Carterra Biologics Symposium

Biologics symposium slated for May 31 in Seattle, WA

ALBANY, N.Y. and SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization and Carterra Inc., the world leader in label-free high throughput antibody and small molecule drug discovery, today announced their partnership in hosting a high-throughput biologics symposium slated for May 31 at the Residence Inn at Marriott in Seattle, Washington.

The purpose of the collaboration is to promote the rising biotech focus within the Pacific Northwest region of the U.S and Canada. The symposium will bring together all levels of scientific leadership from the biotech and pharma communities.

“We are thrilled to be partnering with Carterra to organize this antibody discovery symposium, bringing the Pacific Northwest biotech community together and sharing the latest advances in antibody discovery,” said Steve Lavezoli, Vice President of Biologics at Curia. “We are also looking forward to sharing our optimal, high-quality and accelerated antibody discovery workflows to first-to-human antibody discovery, development and clinical manufacturing. Antibodies discovered and/or engineered with Curia’s platform technology are in the clinic and we have over 230 successful antibody discovery campaigns performed for the biotech community.”

Speed, scientific expertise and efficiency can surmount the high attrition rates of early antibody discovery and achieve first-to-market delivery of new therapeutics. The symposium will highlight Curia’s technology platform and integrated services with a focus on the development of enhanced mouse systems for antibody generation and high-throughput single B cell screening. The combination of next generation sequencing (NGS) and rapid recombinant production of milligram to gram quantities of purified monoclonal antibody (mAb) significantly accelerates identification of development candidate leads.

Since 2017, Carterra has been selling its powerful LSA® high-throughput biosensor to analyze and characterize antibodies using Surface Plasmon Resonance (SPR). With the launch of its LSAXT platform last year, Carterra now offers products that can perform small molecule analysis as well as antibody discovery. The LSA platform has been profiled in several peer-reviewed papers in Science, Nature and Cell, detailing the path of multiple therapeutics entering clinical trials. At the symposium, several leading scientists in biopharma will be sharing their insights into their specific areas of drug discovery and will highlight the transformative impact of integrating HT-SPR technology, AI/ML and other new technologies.

“We are excited to be partnering with Curia on our symposium. Carterra symposia are scientific events that we host each year throughout the U.S. and Europe,” stated Chris M. Silva, Vice President of Marketing and Product at Carterra. “These symposia help us to share the latest technology advancements and important data generated from the workflows of scientists using Carterra’s label-free platforms. Coming to the Pacific Northwest is an opportunity to create a deeper understanding of the technology in pharma and biotechs in this region.”

Click here to RSVP for the event. Registration is required as seating is limited.

About Curia:
Curia is a Contract Development and Manufacturing Organization (CDMO) with over 30 years of experience, an integrated network of 27 global sites and over 3,500 employees partnering with Biopharmaceutical customers to bring life-changing therapies to market. Our biologics and small molecules offerings span discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to improve patients’ lives. Visit us at curiaglobal.com.

About Carterra, Inc.:
Carterra, Inc. is a privately held company. Its HT-SPR technology provides large-molecule and small-molecule drug discovery customers with screening and characterization throughput and functionality that scales with omics-level applications, condensing months of work down to days. Our solutions have enabled multiple therapeutics and breakthrough research and helped academic and translational researchers and biopharmaceutical companies in oncology, immunology, neuroscience, and more.  Carterra is based in Salt Lake City, Utah, and has Customer Experience Centers in San Francisco, Salt Lake City, Boston, Manchester, England, and Munich, Germany. Carterra products are available in Asia-Pacific and Oceania through our exclusive distributor, Revvity. To learn more, visit www.carterra-bio.com or connect with us on LinkedIn or X (Twitter).

Curia Contact Information:
Viana Bhagan
+1 518 512 2111
corporatecommunications@CuriaGlobal.com

Carterra Media Contact:
Cheri Salazar
(408) 594-9400
csalazar@carterra-bio.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/020a0a28-86f0-4f6c-96f2-0eaa01c82784

GlobeNewswire Distribution ID 9114095

Posted on

Arqit warns CISOs why they must act now to secure their data ready for the post-quantum world

LONDON, May 09, 2024 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), a leader in quantum-safe encryption, today urges CISOs and security teams to urgently address their post-quantum technology strategies, as quantum computing advances rapidly. The risk of Store Now, Decrypt Later (SNDL) attacks underscores that the quantum threat is not a distant concern but an immediate security challenge demanding attention today.

Arqit’s distinctive approach addresses the cost and complexity associated with quantum-safe migration strategies through its ground breaking Symmetric Key Agreement Platform (SKA Platform™). Mitigating the risks posed by SNDL attacks is paramount to safeguarding valuable long-term data. Failure to do so could result in a catastrophic breach of data privacy, threatening the secrecy of sensitive and classified information.

Further details may be found in the IDC Analysts Brief: “Securing Valuable and Durable Data in a Post-Quantum World”, sponsored by Arqit

Securing Valuable and Durable Data in a Post-Quantum World (arqit.uk)

David Williams, Chairman and CEO of Arqit Limited said:

“Our cloud-based solution is designed for today’s modern and evolving network environments. Protecting data transmission across diverse communication links and device types necessitates security that is easily deployable, scalable and integrates seamlessly into existing infrastructures without the need for additional hardware. By using well established cryptographic techniques grounded in quantum-resistant symmetric encryption methods, Arqit offers organisations a distinct pathway to transition seamlessly into the post-quantum era.”

Notes to Editors

Arqit representatives will be attending RSA (6-9 May 2024) and will be available for interview. www.rsaconference.com/usa.

For more information about Arqit visit Arqit’s website

IDC Analysts Brief: “Securing Valuable and Durable Data in a Post-Quantum World”, published May 2024, document number IDC #EUR252099724

International Data Corporation (IDC) is the premier global provider of market intelligence, advisory services, and events for the information technology, telecommunications and consumer technology markets. IDC helps IT professionals, business executives, and the investment community to make fact-based decisions on technology purchases and business strategy. For additional information on IDC, please visit https://www.idc.com.

About Arqit

Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit) supplies a unique encryption software service which makes the communications links of any networked device, cloud machine or data at rest secure against both current and future forms of attack on encryption – even from a quantum computer. Compatible with NSA CSfC Components and meeting the demands of NSA CSfC Symmetric Key Management Requirements Annexe 1.2. and RFC 8784, Arqit’s Symmetric Key Agreement Platform uses a lightweight software agent that allows end point devices to create encryption keys locally in partnership with any number of other devices. The keys are computationally secure and facilitate Zero Trust Network Access. It can create limitless volumes of keys with any group size and refresh rate and can regulate the secure entrance and exit of a device in a group. The agent is lightweight and will thus run on the smallest of end point devices. The product sits within a growing portfolio of granted patents. It also works in a standards compliant manner which does not oblige customers to make a disruptive rip and replace of their technology. Arqit is winner of two GSMA Global Mobile Awards, The Best Mobile Security Solution and The CTO Choice Award for Outstanding Mobile Technology, at Mobile World Congress 2024, recognised for groundbreaking innovation at the 2023 Institution of Engineering and Technology Awards and winner of the National Cyber Awards’ Innovation in Cyber Award and the Cyber Security Awards’ Cyber Security Software Company of the Year Award. Arqit is ISO 27001 Standard certified. www.arqit.uk

Media relations enquiries:
Arqit: pr@arqit.uk

Investor relations enquiries:
Arqit: investorrelations@arqit.uk
Gateway: arqit@gateway-grp.com

Caution About Forward-Looking Statements

This communication includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, may be forward-looking statements. These forward-looking statements are based on Arqit’s expectations and beliefs concerning future events and involve risks and uncertainties that may cause actual results to differ materially from current expectations. These factors are difficult to predict accurately and may be beyond Arqit’s control. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for Arqit to predict these events or how they may affect it. Except as required by law, Arqit does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date this communication is issued. In light of these risks and uncertainties, investors should keep in mind that results, events or developments discussed in any forward-looking statement made in this communication may not occur. Uncertainties and risk factors that could affect Arqit’s future performance and cause results to differ from the forward-looking statements in this release include, but are not limited to: (i) the outcome of any legal proceedings that may be instituted against the Arqit, (ii) the ability to maintain the listing of Arqit’s securities on a national securities exchange, (iii) changes in the competitive and regulated industries in which Arqit operates, variations in operating performance across competitors and changes in laws and regulations affecting Arqit’s business, (iv) the ability to implement business plans, forecasts, and other expectations, and identify and realise additional opportunities, (v) the potential inability of Arqit to successfully deliver its operational technology, (vi) the risk of interruption or failure of Arqit’s information technology and communications system, (vii) the enforceability of Arqit’s intellectual property, and (viii) other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Arqit’s annual report on Form 20-F (the “Form 20-F”), filed with the U.S. Securities and Exchange Commission (the “SEC”) on 21 November 2023 and in subsequent filings with the SEC. While the list of factors discussed above and in the Form 20-F and other SEC filings are considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realisation of forward-looking statements.

GlobeNewswire Distribution ID 9113888

Posted on

Apparel Group and Sandbox VR partnered to bring Virtual Reality Innovation to the Middle East

The collaboration will result in 25 locations in the Middle East by 2028

Apparel Group and Sandbox VR partnered to bring Virtual Reality Innovation to the Middle East
The collaboration will result in 25 locations in the Middle East by 2028

DUBAI, United Arab Emirates, May 09, 2024 (GLOBE NEWSWIRE) — In a groundbreaking move, Apparel Group, a dominant force in the global fashion and lifestyle retail landscape, partners with Sandbox VR, the world’s premier destination for premium location-based virtual reality experiences, in a significant franchise partnership. With over 85 brands and more than 2,200 stores across 14 countries, Apparel Group’s extensive reach solidifies the collaboration’s foundation. This collaboration will begin with 25 locations in the Middle East. The partnership comes on the heels of Sandbox VR’s being named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2024. Earning the number two spot in the Augmented and Virtual Reality category, Sandbox VR is recognized for creating a fully-immersive virtual reality experience for a global audience.

“We are excited to embark on this partnership with Sandbox VR, a company that stands at the forefront of virtual reality innovation,” said Neeraj Teckchandani, CEO of Apparel Group. “This collaboration is not just about expanding our portfolio—it’s about creating groundbreaking experiences that merge technology and entertainment, offering our customers in the Middle East and beyond something truly exceptional. Together, we are setting new benchmarks in the retail and entertainment industries.”

“We’ve received an overwhelmingly positive response at our locations across the US, Europe, and Asia,” said Steve Zhao, founder and CEO of Sandbox VR. “The universal appeal of our experiences is unmatched. We’re excited to partner with Apparel Group as we expand our global footprint and bring our fully-immersive virtual reality adventures to even more audiences worldwide.”

Sandbox VR is now operating in over 46 global locations and expanding rapidly. With 18 locations launched in the last 19 months, each 4,000+ sq ft with multiple holodecks in which guests experience the virtual worlds, Sandbox VR is the fastest-growing location-based VR startup in the world. To accelerate that growth, the company recently announced it is opening its US footprint for franchising in addition to international locations. In an ongoing commitment to inclusivity, Sandbox VR is expanding its multi-language support to encompass a total of seven languages and counting, enabling an even wider audience to partake in its immersive offerings.

“Our expansion into the Middle East is a strategic step towards our global commitment to bring people closer together through world-class immersive experiences,” said Lee Hebditch, Director of Global Franchise Operations at Sandbox VR. “The Apparel Group’s profound regional proficiency and unparalleled achievements make them the perfect global ally for our brand. With this partnership, we’re continuing on our mission to make location-based entertainment more accessible.”

Additionally, in September 2023, Sandbox VR collaborated with Netflix to exclusively launch the Squid Game Virtuals, an experience inspired by their #1 hit series. The success of Squid Game Virtuals broke records as it was the fastest experience to hit $1M in sales. In its first two months, the game generated $4.56M in ticket sales at physical venues and has continued its march toward breaking new records. Most recently, Sandbox VR worked with Netflix to announce a limited-time takeover of its London location to celebrate the release of Rebel Moon — Part Two: The Scargiver where visitors previewed the world of Rebel Moon in a full-body VR experience.

For more information and to make reservations, please visit sandboxvr.com and connect with Sandbox VR on Facebook, Instagram, and TikTok.

ABOUT APPAREL GROUP LLC
Apparel Group is a global fashion and lifestyle retail conglomerate residing at the crossroads of the modern economy – Dubai, United Arab Emirates. Today, Apparel Group caters to thousands of eager shoppers through its 2200+ retail stores and 85+ brands on all platforms while employing over 22,000+ multicultural staff.

Apparel Group has carved its strong presence in the GCC and expanded thriving gateways to market in India, South Africa, Singapore, Indonesia, Thailand, Malaysia, and Egypt. Additionally, clear strategies are in place to enter emerging markets such as Hungary and Philippines.

Apparel Group has created an omni-channel experience, operating brands originating from the USA, Canada, Europe, Australia, and Asia. The brands include leading names in fashion, footwear, and lifestyles such as Tommy Hilfiger, Charles & Keith, Skechers, Aldo, Nine West, Aeropostale, Jamie’s Italian, Tim Hortons, Cold Stone Creamery, Inglot, and Rituals.

Apparel Group owes its amazing growth to the vision and guidance of its dynamic Founder and Chairwoman, Mrs. Sima Ganwani Ved, who has taken the company from strength to strength since its inception in the last two decades.

https://apparelglobal.com/en/

ABOUT SANDBOX VR
Sandbox VR is the world’s premier destination for premium location-based virtual reality games. The company has created the world’s most immersive full-body VR platform and boasts games you can’t play anywhere else. Sandbox VR is now operating in over 46 locations across seven countries and expanding rapidly. Sandbox VR is headquartered in San Francisco, California with offices in Hong Kong and Vancouver. Sandbox VR’s latest round has raised over $37 million from investors including Andreessen Horowitz, Alibaba Entrepreneurs Fund, Gobi Partners, and Craft. Individual investors include Justin Timberlake, Katy Perry, Kevin Durant and Will Smith.

Media Contacts:
PR@apparelglobal.com
sandboxvr@inkhouse.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ec651223-8fa3-4aef-8518-a2993aeabeea

GlobeNewswire Distribution ID 9113692

Posted on

HBL Growth Fund Announces 12% Distribution for Fiscal Year 2023

Karachi, HBL Growth Fund has announced a 12% distribution for the fiscal year ending 2023, according to financial announcements from the Pakistan Stock Exchange (PSE). The mutual fund, which operates under the symbol "HBL Growth Fund - (A) NC," closed at a rate of Rs. 7.19. The fund has a paid-up capital of Rs. 3,782,000.

The fund's distribution rate remains consistent with the previous year's performance, showcasing its stability in the market. Listed since 1980, HBL Growth Fund continues to be a reliable investment vehicle within the mutual fund segment on the PSE.

Posted on

Tri-Star Mutual Fund Reports No Distribution for Fiscal Year 2023

Karachi, Tri-Star Mutual Fund has reported no distribution for the fiscal year ending 2023, according to the latest financial disclosures from the Pakistan Stock Exchange (PSE). The fund, symbolized as "Tri-Star Mutual Fund NC," closed at a rate of Rs. 10.

The fund, with a paid-up capital of Rs. 252,000, reported an earnings per share (EPS) of negative Rs. 3.26 for the period of January to April 2024. Tri-Star Mutual Fund has been listed since 1994.

Posted on

Highnoon Laboratories Ltd. Achieves High Closing Price and Distributions

Karachi, Highnoon Laboratories Ltd. closed at Rs. 668.84 and announced a substantial 200% distribution along with a 10% bonus for the year ending April 2024. The company also declared a 300% distribution for the previous period. Highnoon Laboratories Ltd., listed since 1995, has a paid-up capital of Rs. 176.49 million and an EPS of Rs. 57.71 for 2022/2023.

Posted on

B.F. Modaraba Posts Negative Earnings for 2024

Karachi, B.F. Modaraba has reported a challenging financial performance for the period ending in April 2024. The company recorded an earnings per share (EPS) of -0.80. No distributions were announced for the period. The paid-up capital is reported to be Rs. 33,000 million.